CIK 0001590877
- Non-accelerated filer
- Smaller reporting company
REGENXBIO Inc.
Sign in to watch- Ticker
- RGNX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 471851754
- Phone
- +1 240-552-8181
- Business address
- 9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Former names
- ReGenX Biosciences, LLC
- Open-market buys, last 90 days
- $949,381
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-09 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion | +10,000 | $12.10 | $121K | 11,141 |
| 2018-04-09 | Christmas Patrick J. SVP, General Counsel | Sale | −10,000 | $34.00 | $340K | 1,141 |
| 2018-04-09 | Christmas Patrick J. SVP, General Counsel | Exercise or conversion · Employee Stock Option (Right to Buy) | −10,000 | 115,000 | ||
| 2018-03-26 | Vasista Vittal Chief Financial Officer | Sale | −5,000 | $30.00 | $150K | 157,283 |
| 2018-03-20 | Mills Kenneth T. President and CEO | Sale | −10,000 | $29.55 | $296K | 228,530 |
| 2018-03-13 | Simpson Curran SVP, Technical Operations | Exercise or conversion | +25,000 | $22.00 | $550K | 64,500 |
| 2018-03-13 | Simpson Curran SVP, Technical Operations | Sale | −25,000 | $33.00 | $825K | 39,500 |
| 2018-03-13 | Simpson Curran SVP, Technical Operations | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 155,500 | ||
| 2018-03-06 | Vasista Vittal Chief Financial Officer | Exercise or conversion | +60,000 | $0.85 | $51K | 162,283 |
| 2018-03-06 | Vasista Vittal Chief Financial Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −60,000 | 234,900 | ||
| 2018-02-28 | Vasista Vittal Chief Financial Officer | Sale | −5,000 | $30.00 | $150K | 102,283 |
| 2018-02-20 | Mills Kenneth T. President and CEO | Sale | −10,000 | $26.56 | $266K | 238,530 |
Page 43 of 43 · 852 trades